Breztri Aerosphere (budesonide/glycopyrronium/ formeterol fumarate dihydrate)

pCPA File Number: 21595

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Obstructive Pulmonary Disease (COPD)

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

SR0675-000

pCPA Engagement Letter Issued:

2022-02-28

Negotiation Process Concluded:

2022-06-15